Orakl Oncology
Villejuif
About Orakl Oncology
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.7M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Oct 2025)
- Website: orakl-oncology.com
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orakl-oncology-13128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.